FKBP5 rs9296158: Genetic Variation and Stress Sensitivity
The rs9296158 variant is a single-nucleotide polymorphism located in an intronic region of the FKBP5 gene. It acts as part of a well-characterized regulatory haplotype that modulates the body's hypothalamic-pituitary-adrenal axis and cellular sensitivity to glucocorticoid stress hormones. Research has linked this variant to individual differences in stress reactivity and vulnerability to trauma-related psychiatric phenotypes, although the overall evidence remains limited.
What each genotype means
Typical HPA axis reactivity
You carry two copies of the common G allele, which is typically considered the baseline or non-risk genotype in hypothalamic-pituitary-adrenal (HPA) axis studies. Research suggests individuals with this genotype show standard glucocorticoid receptor sensitivity and normal regulation of cortisol feedback after stressful events. However, because findings are derived from candidate gene and gene-environment interaction studies, evidence remains limited and actual psychological resilience depends heavily on overall life environment and broad genetic factors.
Carried by approximately 35% to 40% of individuals of European ancestry, and is also common in other global populations.
Altered stress response vulnerability
You carry one copy of the A risk allele and one copy of the G allele. Published studies have linked the A allele to altered FKBP5 induction, increased glucocorticoid receptor sensitivity, and enhanced susceptibility to post-traumatic stress symptoms following significant life trauma. These statistical associations represent limited candidate gene evidence with mixed findings across different cohorts, so having this genotype does not cause or diagnose any mental health condition.
Carried by roughly 45% to 50% of people of European ancestry, representing the most common genotype in populations with intermediate allele frequencies.
Elevated trauma-related stress sensitivity
You carry two copies of the A allele, which has been investigated as a risk marker in interaction with childhood abuse or severe trauma for developing post-traumatic stress symptoms and altered cortisol suppression. Biological models suggest this genotype may lead to heightened glucocorticoid receptor sensitivity and dysregulated negative feedback in the stress response system. Because published findings are based on candidate gene association studies with acknowledged replication limits, this genotype indicates a potential vulnerability rather than a clinical outcome.
Carried by approximately 10% to 15% of individuals of European ancestry, with varying frequencies across other global ancestries.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism rs9296158 resides within an intronic sequence of the FKBP5 gene, located on chromosome 6. Rather than altering an amino acid in a protein-coding sequence, rs9296158 represents a non-coding regulatory variant. Genomic mapping shows that it exists in high linkage disequilibrium with several other markers across FKBP5, forming an extended haplotype that spans more than 500 kilobases. Within European populations, rs9296158 frequently tags this functional haplotype alongside other widely studied variants, such as rs1360780 and rs3800373. Because it sits in a non-coding region, its physiological effects are primarily mediated through altered gene regulation rather than structural protein disruption. Researchers utilize rs9296158 as an informative genetic marker to track how specific inherited patterns in FKBP5 correspond to glucocorticoid signaling efficiency and altered neuroendocrine reactivity across diverse study cohorts.
Biological Role of the FKBP5 Gene and the HPA Axis
The FKBP5 gene encodes FK506 binding protein 51, a critical co-chaperone that interacts directly with heat shock protein 90 and the glucocorticoid receptor complex. When bound to the receptor, FKBP51 reduces its affinity for cortisol, the primary human stress hormone, thereby acting as a natural molecular brake on glucocorticoid signaling. Cortisol activation normally induces FKBP5 expression, creating an ultra-short intracellular negative feedback loop that terminates the stress response and allows the hypothalamic-pituitary-adrenal axis to regain homeostasis. Genetic variations that alter the sensitivity or expression of FKBP5 can impair this negative feedback mechanism. Such molecular dysregulation can lead to prolonged cortisol exposure during acute stress, heightened amygdala reactivity, and altered physiological recovery following environmental adversity.
Current Scientific Evidence and Psychiatric Phenotypes
Candidate gene studies and genome-wide association studies have repeatedly examined rs9296158 for links to psychiatric traits, particularly post-traumatic stress disorder, major depressive disorder, and heightened anxiety sensitivity. A substantial body of research highlights gene-by-environment interactions, showing that individuals carrying the putative risk alleles exhibit elevated symptom severity primarily when exposed to severe childhood trauma or chronic psychosocial stress. However, the scientific evidence supporting rs9296158 as an independent causative factor remains categorized as limited. Large-scale psychiatric genetics consortia emphasize that trauma vulnerability and depressive symptoms are highly polygenic traits shaped by hundreds of loci across the genome, rather than single intronic variants. Furthermore, associations often diminish or vary when evaluated across ancestral groups outside of European cohorts, indicating significant heterogeneity.
Navigating Genetic Results and Clinical Perspective
Understanding your rs9296158 genotype provides educational insight into one element of stress biology, but it cannot be used to diagnose any mental health condition or predict how an individual will cope with adversity. Complex psychological outcomes are determined by dynamic intersections of life history, social support, early development, lifestyle factors, and overall genetic background. Direct-to-consumer genetic findings involving rs9296158 have no recognized utility for medical decision-making or altering treatment plans. Individuals undergoing medical care for stress, mood disorders, or psychiatric conditions should never alter or initiate pharmacotherapies based on candidate SNP results. Any clinical evaluation, diagnosis, or discussion regarding medication management must always be conducted directly with a qualified healthcare provider or clinical genetic specialist.
How common is this variant?
The minor A allele occurs at a frequency of approximately 0.38 in populations of European ancestry according to gnomAD data, while frequencies can vary markedly in non-European ancestral groups.
Frequently asked questions
What does the FKBP5 rs9296158 variant do in the body?
The rs9296158 variant is an intronic marker within FKBP5 that is associated with differences in how glucocorticoid receptors respond to stress hormones like cortisol. Carrying certain alleles can alter the regulation of the gene, potentially affecting how the body terminates its acute stress response.
Does having the rs9296158 risk allele mean I will develop PTSD?
No, having an associated allele does not mean you will develop post-traumatic stress disorder or depression. Stress-related conditions are complex and shaped by an array of environmental factors, personal resilience, life events, and polygenic influences throughout the genome.
Can rs9296158 testing guide my psychiatric medications?
Current clinical pharmacogenomic guidelines, such as those from CPIC, do not recommend dosing or selecting psychiatric medications based on rs9296158 status. Always consult a physician or clinical pharmacist before considering any changes to prescribed medications.
Why is the evidence for rs9296158 considered limited?
While multiple candidate gene studies observe statistical links between rs9296158 and trauma sensitivity, large-scale genome-wide association studies show that stress-related disorders involve thousands of small genetic variants. In addition, many initial findings have not replicated consistently across diverse ancestral populations.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9296158?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.
Functional polymorphism in FKBP5 that modulates ultradian and stress-induced cortisol secretion and alters recovery trajectories following acute psychological stress.